Garden Grove, CA – According to filings with the U.S. Securities and Exchange Commission, Hycor Holdings is raising $6,000,000.00 in new funding. Sources indicate as part of senior management President, Fei Li played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Hycor Holdings

Founded in 1981, HYCOR Biomedical is a global manufacturer and marketer of in vitro diagnostic products. Since its founding, HYCOR has served the allergy diagnostic testing needs of clinical laboratories, hospitals and doctors’ offices worldwide. The recently launched NOVEOS builds upon 40 years of experience in specific IgE testing, and supplements the Company’s existing line of HYTEC products. The company is focused on delivering NOVEOS, a new generation of fully-automated allergy system that solves the shortcomings of today’s technology, with 1/10th the sample requirement and negligible interference issues.

To learn more about Hycor Holdings, visit http://www.hycorbiomedical.com/

Contact:
Fei Li, President
800-382-2527
fli@hycorbiomedical.com
https://www.linkedin.com/in/fei-li-1b21ab5/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved